Drugs / Wetvax
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00063856 | Jul 2003 → Jun 2004 | smallpox | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1/2 | NCT00038987 | May → Aug 2002 | smallpox | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wetvax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00038987 ↗ |
| Known as | APSV | “Wetvax (APSV)” NCT00038987 ↗1“Wetvax (APSV)” NCT00063856 ↗ |